NERVGEN PHARMA CORP. NGEN
- NVG-291 — Spinal Cord Injury Phase 1
- NVG-300 — Ischemic Stroke Preclinical
- NVG-300 — Spinal Cord Injury Preclinical
Home › Targets › LAR family phosphatases
LAR family phosphatases (1 companies · 3 programs)
Companies with an active program directed at LAR family phosphatases.